Crescenteric amniotic membrane grafting in keratoprosthesis-associated corneal melt

Archives of Ophthalmology

Volumn 128, Issue 6, 2010, Pages 779-782

  Tay, Evelyn ^a,b   Utine, Canan Asli ^a,c   Akpek, Esen K ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c YEDITEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; CYCLOSPORIN; MEDROXYPROGESTERONE ACETATE; MOXIFLOXACIN; NYLON; VANCOMYCIN;

AGED; AMNION; ANAMNESIS; ARTICLE; CASE REPORT; CORNEA; CORNEA DISEASE; CORNEA SURGERY; CORNEA VASCULARIZATION; CORNEAL MELT; DISPOSABLE EQUIPMENT; EPITHELIZATION; FEMALE; HUMAN; KERATOPROSTHESIS; PRIORITY JOURNAL; SHELF LIFE; SLIT LAMP; SUTURE; VISUAL ACUITY;

AGED, 80 AND OVER; AMNION; ARTIFICIAL ORGANS; CORNEA; CORNEAL DISEASES; DESICCATION; FEMALE; HUMANS; PROSTHESES AND IMPLANTS; TRANSPLANTATION, HOMOLOGOUS; VISUAL ACUITY;

EID: 77953642079     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.95     Document Type: Article

References (15)

1. Zerbe BL, Belin MW, Ciolino JB; Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology. 2006;113(10):1779, e1-e7.
2. Dunlap K, Chak G, Aquavella JV,Myrowitz E, Utine CA, Akpek E. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation [published online January 20, 2010]. Ophthalmology. doi:10.1016/j.ophtha.2009.09.024.
3. KhanBF, Harissi-DagherM,KhanDM,DohlmanCH. AdvancesinBostonkeratoprosthesis:enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin. 2007;47(2):61-71.
4. Hicks CR, Crawford GJ. Melting after keratoprosthesis implantation: the effects of medroxyprogesterone. Cornea. 2003;22(6): 497-500.
5. Dohlman CH, Dudenhoefer EJ, Khan BF, Morneault S. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J. 2002;28(2):72-74.
6. Sayegh RR, Ang LPK, Foster S, Dohlman CH. The Boston keratoprosthesis in Stevens- Johnson Syndrome. Am J Ophthalmol. 2008; 145(3):438-444.
7. Clewes AR, Tunn EJ, Kaye S, Bucknall RC. Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not? Rheumatology (Oxford). 2005;44(2):257-258. (Pubitemid 40277416)
8. Gottsch JD, Akpek EK. Topical cyclosporine stimulates neovascularization in resolving sterile rheumatoid central corneal ulcers. Trans Am Ophthalmol Soc. 2000;98:81-87.
9. John T. Human amniotic membrane transplantation: past, present and future. Ophthalmol Clin North Am. 2003;16(1):43-65, vi. (Pubitemid 36384126)
10. Dekaris I, Gabric N, Mravicic I, et al. Multilayer vs monolayer amniotic membrane transplantation for deep corneal ulcer treatment. Coll Antropol. 2001; 25(suppl):23-28. (Pubitemid 33743263)
11. Kruse FE, Rohrschneider K, Volcker HE. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology. 1999; 106(8):1504-1510.
12. Hanada K, Shimazaki J, Shimmura S, Tsubota K. Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera. Am J Ophthalmol. 2001;131(3):324-331. (Pubitemid 32184517)
13. Azuara-Blanco A, Pillai CT, Dua HS. Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol. 1999;83(4):399-402. (Pubitemid 29161178)
14. Rodríguez-Ares MT, Tourinõ R, López- Valladares MJ, Gude F. Multilayer amniotic membrane transplantation in the treatment of corneal perforations. Cornea. 2004;23(6):577-583.
15. Hick S, Demers PE, Brunette I, La C, Mabon M, Duchesne B. Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea. 2005;24(4):369-377.